ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

GSK Gsk Plc

1,351.50
10.00 (0.75%)
Last Updated: 10:11:04
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  10.00 0.75% 1,351.50 1,351.00 1,352.00 1,353.00 1,341.00 1,341.00 1,034,529 10:11:04
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1889 11.37 55.61B
Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,341.50p. Over the last year, Gsk shares have traded in a share price range of 1,282.50p to 1,820.00p.

Gsk currently has 4,145,087,815 shares in issue. The market capitalisation of Gsk is £55.61 billion. Gsk has a price to earnings ratio (PE ratio) of 11.33.

Gsk Share Discussion Threads

Showing 29626 to 29648 of 34075 messages
Chat Pages: Latest  1195  1194  1193  1192  1191  1190  1189  1188  1187  1186  1185  1184  Older
DateSubjectAuthorDiscuss
19/2/2022
08:58
GlaxoSmithKline (GSK) is now just months away from publishing results which it expects will show that its latest RSV jab is safe and effective.

Data is due in early 2022, and the vaccine is expected to be approved and in use by next winter.

Dr Jamila Louahed, the vice-president of vaccine research and development at GSK, told The Telegraph that the pharmaceutical company has been working towards this moment for decades, and is now on the verge of a breakthrough.

“We have to wait for the data to be certain, but I am quite comfortable saying there is a high probability that the vaccine will work,” she said.

tradermichael
19/2/2022
06:30
Nearly £6.5 million worth of free shares for 'performance'. Surely they owe it to ordinary shareholders to explain this performance if it is considered to be good or bad.
krowelet
18/2/2022
23:12
This company is certainly not run in the best interest of the shareholders.
spoole5
18/2/2022
22:13
This ceo is massively overpaid....

More vesting of awards....

412000 odd shares



Most of the RNS for this company seem to relate to share awards all the time.

Turns dowm an easy wedge of cash from Unilever...
Pressure now on to make sure the demerger "works"

geckotheglorious
18/2/2022
14:51
It will likely get a another kick in that direction next Thursday when they go ex-divi. £17+ looks very good from where we are now.
jonjoneil
18/2/2022
13:38
Drifting towards 1500 by the split, the refusal looking more idiotic by the day.
spoole5
18/2/2022
11:59
Do you think these 'blokers' ever talk to each other?
If you want a more realistic forecast - Emma says 'buy 2350'!

jonjoneil
18/2/2022
11:31
15-Feb-22 Liberum Capital Buy 1,910.00 (up from 1870p)
tradermichael
18/2/2022
10:42
Ha Ha jj - it certainly made me feel better!
spyder
18/2/2022
10:40
found the ref on LSE site. But no detail of course
jonjoneil
18/2/2022
10:17
spyder
do you have a link to the HSBC rating? I can't find any reference to it. You didn't make it up to make people like me feel better?

jonjoneil
18/2/2022
10:06
Not sure that strategy will work this time around net ...
spyder
18/2/2022
09:47
tempting for 1% dividend of pre-dividend bounce on monday/tuesday...
early days.

netcurtains
18/2/2022
08:33
Mixed news today, GSK has suspended its Phase III trials of its RSV vaccine in pregnant women, but, HSBC raises target price to 2170p from 2000p
spyder
17/2/2022
11:11
The majority of the offer was cash
spoole5
16/2/2022
21:53
if we d had taken their shares in part payment that has gone down after the offer so we d have lost either way though not as much
would have been fine if it was an all cash offer

billionairepaddy
16/2/2022
21:30
Eloquently put and sadly very true!Like many I should have sold when it peaked over £17
gateside
16/2/2022
17:05
Deutsche marked GSK down to £15. I listened to Emma and now I'm confused.
Anyone have access to their reasoning?

jonjoneil
16/2/2022
09:12
Maybe Elliot is pulling some out ?
panache1
16/2/2022
08:44
I was thinking that too!
charlie9038
16/2/2022
08:39
Had to check it wasn't ex div!
spoole5
15/2/2022
14:49
My thoughts were indeed for those that fall into that category,as they say to whom it may or may not concern !
abdullla
15/2/2022
14:17
Have you missed a zero or two off that?
pander45
Chat Pages: Latest  1195  1194  1193  1192  1191  1190  1189  1188  1187  1186  1185  1184  Older

Your Recent History

Delayed Upgrade Clock